Skip to content
Independent analysis of NHS open data
PharmaInsight

Emtricitabine/Rilpivirine/Tenofovir alafenamide vs Aciclovir

National NHS prescribing compared (Prescription Cost Analysis)
Data updated April 2026

Aciclovir was dispensed 109,300.0× as often as Emtricitabine/Rilpivirine/Tenofovir alafenamide in April 2026 — 109,300 items versus 1 in England.

1items

Emtricitabine/Rilpivirine/Tenofovir alafenamide · April 2026

NHSBSA Prescription Cost Analysis

109,300items

Aciclovir · April 2026

NHSBSA Prescription Cost Analysis

Figure 1. Emtricitabine/Rilpivirine/Tenofovir alafenamide versus Aciclovir: national items dispensed by month

▬ Emtricitabine/Rilpivirine/Tenofovir alafenamide   ·   ╌ Aciclovir

0 56k 112k Jan 2026 Apr 2026 Aciclovir 1 Jan 2026: 2 Apr 2026: 1

Source: NHSBSA Prescription Cost Analysis, to April 2026

Emtricitabine/Rilpivirine/Tenofovir alafenamide versus Aciclovir, April 2026
Measure Emtricitabine/Rilpivirine/Tenofovir alafenamide Aciclovir
Items, April 2026 1 109,300
Items, last 12 months 3 1,279,503
Net ingredient cost, April 2026 £491 £293,010

See the full profile for Emtricitabine/Rilpivirine/Tenofovir alafenamide or Aciclovir.